Jonathan McNeill, President and COO at CRESCENT BIOPHARMA, INC. (CBIO), sold 20,549 shares at $17.99 ($370K) on 2026-06-22, disclosed to the SEC on 2026-06-23.
Scheduled sale ($370k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DYN | SELL | 2024-06-11 | $114K | — | Filing → |
| DYN | SELL | 2024-05-17 | $143K | — | Filing → |
| DYN | SELL | 2024-03-13 | $5.2M | — | Filing → |